Bionano Genomics (Bionano Genomics) FCF Margin % : -321.10% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Bionano Genomics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bionano Genomics's Free Cash Flow for the three months ended in Mar. 2024 was $-28.16 Mil. Bionano Genomics's Revenue for the three months ended in Mar. 2024 was $8.77 Mil. Therefore, Bionano Genomics's FCF Margin % for the quarter that ended in Mar. 2024 was -321.10%.

As of today, Bionano Genomics's current FCF Yield % is -164.74%.

The historical rank and industry rank for Bionano Genomics's FCF Margin % or its related term are showing as below:

BNGO' s FCF Margin % Range Over the Past 10 Years
Min: -460.82 Med: -358.53 Max: -168.95
Current: -326.28

During the past 8 years, the highest FCF Margin % of Bionano Genomics was -168.95%. The lowest was -460.82%. And the median was -358.53%.

BNGO's FCF Margin % is ranked worse than
86.58% of 827 companies
in the Medical Devices & Instruments industry
Industry Median: -7.24 vs BNGO: -326.28

Bionano Genomics FCF Margin % Historical Data

The historical data trend for Bionano Genomics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionano Genomics FCF Margin % Chart

Bionano Genomics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-292.11

-450.59

-408.14

-460.82

-351.29

Bionano Genomics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-441.98	-429.54	-282.98	-284.71	-321.10

Competitive Comparison of Bionano Genomics's FCF Margin %

For the Medical Instruments & Supplies subindustry, Bionano Genomics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bionano Genomics's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bionano Genomics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Bionano Genomics's FCF Margin % falls into.

Bionano Genomics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Bionano Genomics's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-126.872	/	36.116
	=	-351.29 %

Bionano Genomics's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-28.157	/	8.769
	=	-321.10 %

Bionano Genomics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Bionano Genomics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bionano Genomics (Bionano Genomics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bionano Genomics Inc (NAS:BNGO) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

BNGO:Mexico

Address

9540 Towne Centre Drive, Suite 100, San Diego, CA, USA, 92121

Website

https://bionano.com

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas.

Executives

Gulsen Kama	officer: Chief Financial Officer	C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO CA 92121
Hannah Mamuszka	director	C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO CA 92121
R. Erik Holmlin	director, officer: President and CEO	4088 COMMERCIAL AVE., NORTHBROOK IL 60062
Christopher P. Stewart	officer: Chief Financial Officer	C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO CA 92121
Jonathan V. Dixon	officer: General Counsel	C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO CA 92121
Yvonne Linney	director	C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO CA 92121
David L Barker	director	9885 TOWNE CENTRE DR, SAN DIEGO CA 92121
Aleksandar Rajkovic	director	9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO CA 92121
Vincent Jung-fai Wong	director	C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO CA 92121
Soheil Shams	officer: Chief Informatics Officer	C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO CA 92121
Richard Shippy	officer: Chief Business Officer	C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO CA 92121
Robert J Priar	officer: Chief Commercial Officer	C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO CA 92121
Alka Chaubey	officer: Chief Medical Officer	C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO CA 92121
Heather Adams	officer: Chief Administrative Officer	C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO CA 92121
Kristiina Md Vuori	director	C/O WEBMD HEALTH CORP., 111 EIGHTH AVENUE, NEW YORK NY 10011